Status:
RECRUITING
Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.
Detailed Description
Cancer-related fatigue is experienced by nearly all patients during treatment, and cancer-related cognitive impairment (CRCI), which is a decrease in neurocognitive functioning that can be caused by c...
Eligibility Criteria
Inclusion
- Current diagnosis of cancer.
- Ages 18 and over.
- Has access to a device (smart phone, computer, tablet) with internet access.
- Participant is willing and able to give informed consent for participation in the study.
Exclusion
- Females who are pregnant or lactating.
- Other medical conditions or medications deemed exclusionary by the study investigators.
Key Trial Info
Start Date :
March 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06098404
Start Date
March 4 2024
End Date
October 1 2026
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Medical Branch
Galveston, Texas, United States, 77555